Synbio International, Inc. (SYIN)
OTCMKTS
· Delayed Price · Currency is USD
0.0020
+0.0002 (11.11%)
Mar 6, 2025, 4:00 PM EST
Synbio International Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
538.04K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | - | - | - |
| Dec 31, 2007 | 98.56K | -16.39K | -14.26% |
| Dec 31, 2006 | 114.95K | 925.00 | 0.81% |
| Dec 31, 2005 | 114.02K | - | - |
| Dec 31, 2004 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.18B |
| SS Innovations International | 16.04M |
| Veradigm | 1.53B |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 188.29M |
| Northwest Biotherapeutics | 1.60M |
| Silence Therapeutics | 43.26M |
| BioStem Technologies | 210.49M |